These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32263417)

  • 1. An amphipathic lytic peptide for enhanced and selective delivery of ellipticine.
    Lu S; Ding Y; Wu Y; Wang R; Pan R; Wan Z; Xu W; Zhang L; Yuan YF; Chen P
    J Mater Chem B; 2016 Jun; 4(24):4348-4355. PubMed ID: 32263417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
    Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
    Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis.
    Bawa R; Fung SY; Shiozaki A; Yang H; Zheng G; Keshavjee S; Liu M
    Nanomedicine; 2012 Jul; 8(5):647-54. PubMed ID: 21889478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
    Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Characterization of a Multifunctional pH-Triggered Peptide C8 for Selective Anticancer Activity.
    Lu S; Bennett WF; Ding Y; Zhang L; Fan HY; Zhao D; Zheng T; Ouyang PK; Li J; Wu Y; Xu W; Chu D; Yuan Y; Heerklotz H; Karttunen M; Chen P
    Adv Healthc Mater; 2015 Dec; 4(17):2709-18. PubMed ID: 26474414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems.
    Dan VM; Varghese TS; Viswanathan G; Baby S
    Curr Cancer Drug Targets; 2020; 20(1):33-46. PubMed ID: 31560288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition.
    Lu S; Wang H; Sheng Y; Liu M; Chen P
    J Control Release; 2012 May; 160(1):33-40. PubMed ID: 22465389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine-rich ionic complementary peptides as potential drug carriers: Impact of peptide sequence on size, shape and cell specificity.
    Wan Z; Lu S; Zhao D; Ding Y; Chen P
    Nanomedicine; 2016 Aug; 12(6):1479-88. PubMed ID: 26949161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.
    Ma W; Lu S; Pan P; Sadatmousavi P; Yuan Y; Chen P
    PLoS One; 2012; 7(8):e43684. PubMed ID: 22952737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of New Benzodioxole- Based Thiosemicarbazone Derivatives as Potential Antitumor Agents.
    Altıntop MD; Temel HE; Sever B; Akalın Çiftçi G; Kaplancıklı ZA
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27879683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells.
    Indra R; Černá T; Heger Z; Hraběta J; Wilhelm M; Dostálová S; Lengálová A; Martínková M; Adam V; Eckschlager T; Schmeiser HH; Arlt VM; Stiborová M
    Toxicology; 2019 May; 419():40-54. PubMed ID: 30914192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.
    Hisamatsu Y; Shibuya A; Suzuki N; Suzuki T; Abe R; Aoki S
    Bioconjug Chem; 2015 May; 26(5):857-79. PubMed ID: 25875312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
    Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
    Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
    Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
    Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents.
    Turan-Zitouni G; Altıntop MD; Özdemir A; Kaplancıklı ZA; Çiftçi GA; Temel HE
    Eur J Med Chem; 2016 Jan; 107():288-94. PubMed ID: 26599534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-dimensional poly(L-lysine)-block-poly(L-threonine) assemblies exhibit potent anticancer activity by enhancing membranolysis.
    Chen YF; Shiau AL; Chang SJ; Fan NS; Wang CT; Wu CL; Jan JS
    Acta Biomater; 2017 Jun; 55():283-295. PubMed ID: 28412555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Cytotoxic Potentials of Some Isoindole-1, 3-Dione Derivatives on HeLa, C6 and A549 Cancer Cell Lines.
    Tan A; Yaglioglu AS; Kishali NH; Sahin E; Kara Y
    Med Chem; 2020; 16(1):69-77. PubMed ID: 30520382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
    Makovitzki A; Fink A; Shai Y
    Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
    Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
    Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Tumor Cells Using a pH-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure.
    Wang S; Wang T; Zhang J; Xu S; Liu H
    Langmuir; 2018 Jul; 34(30):8818-8827. PubMed ID: 29914261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.